Ninth Annual Controversies in Hematologic Malignancies Symposium

Milwaukee, WI US
February 29, 2020

This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include Hodgkin lymphoma, TKI's for CML, precision medicine, antifungal prophylaxis, cellular therapy for myeloma, updates in acute leukemia and more. 

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists and Registered Nurses

Learning Objectives

The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.

Additional information

CME Coordinator Contact Information

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 5.25 NP Contact Hours
Course opens: 
01/02/2020
Course expires: 
04/29/2020
Event starts: 
02/29/2020 - 7:30am
Event ends: 
02/29/2020 - 3:00pm
Cost:
$0.00

7:30-8:20am | Registration/Breakfast/View Exhibits

8:20-8:30am | Introduction

8:30-9:15am | CLL New Therapies

                        William G. Wierda, MD, PhD,  MD Anderson Cancer Center

9:15-10:00am | Management of NHL in the Elderly

                        Nirav Shah, MD, Medical College of Wisconsin

10:00-10:15am | Break

10:15-11:00am | CARs/BiTEs in Hematologic Malignancies: Approved and Emerging Options

                        Parameswaran Hari, MD, MRCP,  Medical College of Wisconsin

11:00-11:45am | Breakout Sessions

Measurement of Circulating Tumor DNA in Hematologic Malignancies

Timothy Fenske, MD, MS, Medical College of Wisconsin

Relevant Drug-Drug Interactions to Consider with Novel Oral Therapies

Lisa Samanas, PharmD 

Cannabinoids and Cancer

Cecillia J. Hillard, PhD, Medical College of Wisconsin

11:45-12:45pm | Lunch

12:45-1:30pm | Updates in Smoldering Multiple Myeloma

   Natalie Callander, MD, University of Wisconsin Health

1:30-2:15pm | Intensive vs. Less Intensive AML Therapy

                        Laura Michaelis, MD and Ehab Atallah, MD, Medical College of Wisconsin

2:15pm | Adjourn

Hilton Hotel
509 W. Wisconsin Ave.
Milwaukee, WI 53203
United States
+1 (414) 930-1865

Please ask for a complimentary parking ticket at the registration tables on the 5th floor of the Hilton in the Crystal Ballroom. A block of rooms has been reserved at a special rate (single or double occupancy) for the evening of Friday, February 28, 2020. The special room rate will be available under the group name "Medical College of Wisconsin - Hematology" until the group block is sold out.

Guest Speakers

Natalie Callander, MD
Professor of Medicine
Division of Hematology Oncology
University of Wisconsin School of Medicine and Public Health

William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center

Froedtert and the Medical College of Wisconsin Speakers

Ehab Atallah, MD
Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Timothy Fenske, MD
Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin

Parameswaran Hari, MD, MRCP
Professor of Medicine
Chief, Division of Hematology & Oncology
Medical College of Wisconsin 

Cecilia Hillard, PhD
Associate Dean for Research
Director, Neuroscience Research Center
Medical College of Wisconsin 

Laura Michaelis, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin

Nirav Shah, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin

Planning Committee

Sameem Abedin, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Lyndsey Runaas, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Dan Bullock
Education Program Coordinator
Division of Hematology and Oncology
Medical College of Wisconsin

Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin

Robert Taylor, MD
Director of Autologous Stem Cell Transplant Program
Aurora Cancer Care 

Mindy Waggoner, PharmD, BCOP
Oncology Nurse Manager
Pharmacy-Oncology Services
Froedtert Hospital

All persons in control of content have NO relevant financial relationships to dislose with the exception of:

NameCompanyRole
Nirav Shah, MD
Gilead-Kite
 
Mitlenyi Biotech
 
Celgene

Advisory Board

Research/Advisory Board

Advisory Board

Parameswaran Hari, MDBristol Myers Squibb, Janssen, Amgen, Karyopharm, Pharmacyclics, AbbvieConsulting
Timothy Fenske, MD

Genentech. Adaptive Biotechnologies, AbbVie, Verastem, Kite MorphoSys

Seattle Genetics, AstraZeneca,Celgene, Adaptive Biotechnologies

Millennium, Kyowa. TG Therapeutics, Portola, Curis

Consultant

Speaking

Research Funding

William Wierda, MD, PhDNovartis, AbbVie, Genentech, Pharmacyclics, Acerta Pharma, Gilead, Juno Therapeutics, KITE Pharma, Sunesis, Miragen, Oncternal Therapeutics, Cyclacel, Loxo Oncology, Janssen, XencorResearch Funding
Cecilia Hillard, PhD

Phytecs, Inc.

Beryl Therapeutics

Research

Consulting

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 5.25 hours of participation for continuing education for allied health professionals.

Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930.  This program has been approved for 5.25 contact hours of continuing education (which includes 0.75 hours of pharmacology).

 

Available Credit

  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 5.25 NP Contact Hours

Price

Cost:
$0.00
Please login or register to take this course.

This activity is complementary, however registration is required. To register for this course click the "Take Course" button above.